AzTrials
AzTrials

Gait, StumblingNCT05890755

Mimicking Slipping Responses Using a Novel Mechanical Perturbation Algorithm

An observational study of Gait, Stumbling and Gait, Perturbation, run by University of Zurich at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Healthy subjects will be invited to fill out a questionnaire regarding falls and balance skills followed by normal walking trials on a treadmill at 9 different speeds (0.28-1.4 m/s). Key gait parameters for the normative database will be collected. Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Gait, Stumbling, Gait, Perturbation
What is being tested?
Mechanical pertubation
How many people
43 participants
Where
1 siteSwitzerland
Study dates
6 Jun 2023to 6 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Healthy population

Who may be able to join

  • Healthy subjects aged 18-40 years and 60-80 years
  • Ability to walk at minimum 30 minutes at a regular pace without assistance or breaks
  • Written informed consent as documented by signature (see informed consent form)

Who cannot join

  • Women who are pregnant or breast feeding
  • Current neurological problems affecting walking function and balance
  • Current orthopedic problems affecting upper and lower extremity movements
  • History of alcohol abuse or the intake of psychotropic drugs
  • History of major cardiac condition (e.g., infarction, insufficiency (NYHA II-IV))
  • History of major pulmonary condition (e.g., chronic obstructive pulmonary disease (GOLD II-IV))
Show all 9Show fewer
  • Current major depression or psychosis
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia
  • Fever of unknown origin

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Balgrist Campus

    Zurich, Canton of Zurich, 8008

Other trials in Switzerland

About this study

Healthy subjects will be invited to fill out a questionnaire regarding falls and balance skills followed by normal walking trials on a treadmill at 9 different speeds (0.28-1.4 m/s). Key gait parameters for the normative database will be collected. During the perturbation trials, the subjects will walk at a constant speed (1.2 m/s). The treadmill belts are ac, - or decelerated during the perturbations according to three different perturbation algorithms with varying perturbation onset. Movements will be analyzed by 3D motion capture, force plates, surface electromyography and IMU sensors. All methods are non-invasive and commonly used in the field of biomechanics.

Being tested
Mechanical pertubation
Medical subject headings
Gait Disorders, Neurologic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mechanical pertubationOther

    Acceleration or deacceleration of one treadmill gait belt.

Study groups in NCT05890755
Study groupRoleWhat they receive
Healthy participants between 18 and 40 years of ageNot described
Receives: Other: Mechanical pertubation
Healthy participants between 60 and 80 years of ageNot described
Receives: Other: Mechanical pertubation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Calculation of Margins of Stability (MoS) in anterior-posterior direction at foot contact

    Difference between base of support and interpolated center of mass (mm), based on 3D motion capture.

    Measured: Once during visit 1

  2. Step length at baseline, before (Pre) and after (Recovery step 1-10) perturbation

    Measured: Once during visit 1

Secondary outcomes (12)
  1. Step width at foot contact of baseline, before (Pre) and Recovery steps 1-10

    Measured: Once during visit 1

  2. Calculation of Margin of stability medial-lateral direction at foot contact of baseline, before (Pre) and Recovery steps 1-10

    Difference between base of support and interpolated center of mass (mm), based on 3D motion capture.

    Measured: Once during visit 1

  3. Maximal trunk velocity during gait cycle at of baseline, before (Pre) and Recovery steps 1-10 to detect fast trunk movement to gain balance

    Optical markers are placed on the upper body of the subjects and will be used for calculation (distance over time) of the trunk velocity.

    Measured: Once during visit 1

  4. 3D kinematic gait profiles to analyze detailed movement patterns/strategies

    The optical markers are placed according to the Plug-in gait marker set in Vicon Nexus (motion capture system). Hip, knee, ankle and trunk angles are calculated from this marker set.

    Measured: Once during visit 1

  5. EMG analysis to detect reaction time and activity patterns of different leg muscles

    Measured: Once during visit 1

  6. Questionnaire regarding the incidence of falls in the last six months

    Contains questions how often und the reason why the subject falls

    Measured: Once during visit 1

  7. Activities specific Balance Confidence scale (ABC scale)

    Contains 16 questions rating the balance confidence between 0-100%. 100% means absolutely confident in doing some activity

    Measured: Once during visit 1

  8. Questionnaire regarding the perceived intensities of the three perturbation algorithms

    Judging the three pertubation algorithms according to their intensity, inconvenience and how realistic the slipping felt. Scale ranges from 0-10, whereas 10 is the most intense

    Measured: Once during visit 1

  9. Functional Gait Assessment (FGA) as a clinical balance test

    Assess the dynamic stability during different walking tasks. In total, 30 points are possible, at 22 points is the cut off score to classify the fall risk in older adults in predicting falls.

    Measured: Once during visit 1

  10. A set of kinematic parameters

    Measurement of hip, knee, ankle and spine angles during walking in degrees (°).

    Measured: Once during visit 1

  11. A set of kinetic parameters

    Ground reaction forces measured by force plates in Newton (N).

    Measured: Once during visit 1

  12. A set of spatiotemporal parameters

    Stance time, double stance time in seconds (s).

    Measured: Once during visit 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jun 2023
  2. Study start6 Jun 2023
  3. Primary completion6 Dec 2024
  4. Study completion6 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
43 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05890755
Sponsor's protocol ID
2023-00213
Other IDs
2023
Status last verified
Aug 2025
First submitted
31 Mar 2023
Last updated
28 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Gait, Stumbling and Gait, Perturbation, run by University of Zurich at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Calculation of Margins of Stability (MoS) in anterior-posterior direction at foot contact (time frame: Once during visit 1). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in